エル・ティー・エスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/19 | 3,405 | 3,420 | 3,270 | 3,270 | -180 | -5.2% | 38,000 |
2021/08/18 | 3,270 | 3,450 | 3,210 | 3,450 | +175 | +5.3% | 43,500 |
2021/08/17 | 3,325 | 3,380 | 3,260 | 3,275 | -50 | -1.5% | 24,200 |
2021/08/16 | 3,410 | 3,480 | 3,300 | 3,325 | -95 | -2.8% | 48,200 |
2021/08/13 | 3,460 | 3,460 | 3,400 | 3,420 | -10 | -0.3% | 14,700 |
2021/08/12 | 3,505 | 3,525 | 3,430 | 3,430 | -70 | -2% | 20,000 |
2021/08/11 | 3,580 | 3,580 | 3,455 | 3,500 | -95 | -2.6% | 41,700 |
2021/08/10 | 3,430 | 3,645 | 3,430 | 3,595 | +25 | +0.7% | 46,600 |
2021/08/06 | 3,655 | 3,700 | 3,510 | 3,570 | -65 | -1.8% | 30,700 |
2021/08/05 | 3,580 | 3,635 | 3,525 | 3,635 | +15 | +0.4% | 31,500 |
2021/08/04 | 3,650 | 3,730 | 3,610 | 3,620 | -50 | -1.4% | 17,800 |
2021/08/03 | 3,780 | 3,850 | 3,670 | 3,670 | -170 | -4.4% | 23,000 |
2021/08/02 | 3,820 | 3,840 | 3,700 | 3,840 | ±0 | ±0% | 21,900 |
2021/07/30 | 3,995 | 3,995 | 3,820 | 3,840 | -130 | -3.3% | 22,700 |
2021/07/29 | 3,910 | 4,040 | 3,820 | 3,970 | +130 | +3.4% | 83,800 |
2021/07/28 | 4,085 | 4,085 | 3,830 | 3,840 | -245 | -6% | 48,700 |
2021/07/27 | 4,040 | 4,110 | 4,005 | 4,085 | +45 | +1.1% | 28,400 |
2021/07/26 | 4,065 | 4,130 | 4,020 | 4,040 | +5 | +0.1% | 27,400 |
2021/07/21 | 3,970 | 4,040 | 3,925 | 4,035 | +165 | +4.3% | 27,900 |
2021/07/20 | 3,835 | 3,995 | 3,835 | 3,870 | -35 | -0.9% | 39,600 |
2021/07/19 | 4,000 | 4,065 | 3,900 | 3,905 | -145 | -3.6% | 41,900 |
2021/07/16 | 4,065 | 4,070 | 3,995 | 4,050 | -35 | -0.9% | 32,700 |
2021/07/15 | 4,135 | 4,170 | 4,070 | 4,085 | -90 | -2.2% | 25,000 |
2021/07/14 | 4,060 | 4,235 | 4,035 | 4,175 | +175 | +4.4% | 53,500 |
2021/07/13 | 4,140 | 4,140 | 3,995 | 4,000 | -80 | -2% | 27,100 |
2021/07/12 | 4,125 | 4,150 | 4,010 | 4,080 | -30 | -0.7% | 35,400 |
2021/07/09 | 3,950 | 4,110 | 3,925 | 4,110 | +105 | +2.6% | 58,500 |
2021/07/08 | 4,030 | 4,115 | 3,995 | 4,005 | +45 | +1.1% | 56,400 |
2021/07/07 | 3,955 | 4,065 | 3,915 | 3,960 | -40 | -1% | 58,400 |
2021/07/06 | 3,780 | 4,015 | 3,760 | 4,000 | +260 | +7% | 73,300 |
2021/07/05 | 3,800 | 3,960 | 3,725 | 3,740 | -40 | -1.1% | 79,400 |
2021/07/02 | 3,510 | 3,780 | 3,495 | 3,780 | +250 | +7.1% | 76,000 |
2021/07/01 | 3,620 | 3,620 | 3,520 | 3,530 | -125 | -3.4% | 39,000 |
2021/06/30 | 3,740 | 3,740 | 3,630 | 3,655 | -80 | -2.1% | 29,500 |
2021/06/29 | 3,750 | 3,830 | 3,700 | 3,735 | ±0 | ±0% | 58,700 |
2021/06/28 | 3,640 | 3,775 | 3,610 | 3,735 | +135 | +3.8% | 38,300 |
2021/06/25 | 3,650 | 3,650 | 3,585 | 3,600 | +10 | +0.3% | 14,200 |
2021/06/24 | 3,635 | 3,720 | 3,590 | 3,590 | -45 | -1.2% | 34,100 |
2021/06/23 | 3,540 | 3,635 | 3,540 | 3,635 | +100 | +2.8% | 28,800 |
2021/06/22 | 3,500 | 3,545 | 3,455 | 3,535 | +80 | +2.3% | 20,300 |
2021/06/21 | 3,430 | 3,500 | 3,370 | 3,455 | -45 | -1.3% | 27,000 |
2021/06/18 | 3,605 | 3,655 | 3,485 | 3,500 | -75 | -2.1% | 29,800 |
2021/06/17 | 3,640 | 3,640 | 3,560 | 3,575 | -65 | -1.8% | 31,100 |
2021/06/16 | 3,650 | 3,665 | 3,585 | 3,640 | -60 | -1.6% | 34,100 |
2021/06/15 | 3,685 | 3,770 | 3,655 | 3,700 | +40 | +1.1% | 33,400 |
2021/06/14 | 3,605 | 3,685 | 3,570 | 3,660 | +90 | +2.5% | 32,700 |
2021/06/11 | 3,595 | 3,675 | 3,560 | 3,570 | -50 | -1.4% | 37,900 |
2021/06/10 | 3,555 | 3,625 | 3,485 | 3,620 | ±0 | ±0% | 31,800 |
2021/06/09 | 3,540 | 3,630 | 3,510 | 3,620 | +120 | +3.4% | 49,500 |
2021/06/08 | 3,440 | 3,555 | 3,425 | 3,500 | +85 | +2.5% | 43,000 |
801~
850
件表示中 / 1694件
類似銘柄と比較する
現在ご覧いただいている「LTS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
LTS | 230,600円 | +34.8% | +52.7% | 1.30% | 10.71倍 | 2.74倍 |
|
ビジネスプロセス可視化・改善・実行支援など展開、ITビジネスマッチング「アサインナビ」も |
メドピア | 49,100円 | -17.1% | -35.1% | 0.92% | 21.33倍 | 1.13倍 |
|
医師向け情報サイト運営、製薬会社の広告料が収益源。法人向け医療相談や特定保健指導も展開 |
FCE | 97,200円 | +14.9% | +29.6% | 1.44% | 16.86倍 | 3.15倍 |
|
業務改善用RPAソフトでDX支援。クラウドサービスでeラーニング展開。配当性向25%目安 |
MDNT | 4,000円 | +21.1% | - | 0.00% | - | 2.04倍 |
|
東大医科研発。がん免疫細胞療法の細胞加工が核。医薬品開発、医薬品受託製造(CDMO)も |
ZETA | 40,900円 | -54.0% | - | 1.71% | 282.07倍 | 7.62倍 |
|
ZETAを子会社化しビッグデータ活用の推奨商品表示(CX改善)が柱に。ネット広告は撤退 |
市場注目の銘柄
チャート関連のコラム